Status:

COMPLETED

Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic

Lead Sponsor:

Ohio State University

Conditions:

Anxiety

Chronic Pain

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to characterize and improve controlled substance, carisoprodol and tramadol use in an internal medicine residents' clinic. Specific objectives of this study include: * To...

Detailed Description

Reporting workbench will be used to generate a report from the EMR of all patients of consenting physicians prescribed a controlled substance, carisoprodol, or tramadol at least 3 times in the past 6 ...

Eligibility Criteria

Inclusion

  • Age 18 years and older
  • Residents and attending physicians who work in the resident continuity practice

Exclusion

  • Age \< 18 years of age

Key Trial Info

Start Date :

September 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2015

Estimated Enrollment :

96 Patients enrolled

Trial Details

Trial ID

NCT02244099

Start Date

September 1 2014

End Date

March 1 2015

Last Update

September 24 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Ohio State University

Columbus, Ohio, United States, 43210